Dr. Christina D. Schwindt, MD

Dr. Schwindt practices at Surgery Center of Newport in Newport Beach, California.

Dr. Schwindt's NPI, 1366522518, was assigned on October 16, 2006. Dr. Schwindt graduated from Saint Louis University School Of Medicine in 1993. Dr. Schwindt holds California license G84295.

Dr. Schwindt's primary practice is Surgery Center of Newport, at 400 Newport Center Dr, Newport Beach, CA 92660 in Orange County. The practice phone is (949) 644-1648.

Dr. Schwindt's primary practice is Surgery Center of Newport in Newport Beach, California. Dr. Schwindt is also affiliated with Hoag Hospital Newport Beach. The medical group on file is Hoag Clinic. Dmand AI also links Dr. Schwindt to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schwindt practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Schwindt's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Schwindt is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Schwindt's licenses on file in 2 states: California and Maryland.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, hives and immune deficiency disease among the conditions Dr. Schwindt treats.

CMS data shows 4,626 Medicare services from Dr. Schwindt across 10 procedure codes in 2024, for 182 Medicare patients. Medicare paid $74,001 for them. Every service was in an office.

CMS counts 182 Medicare patients who saw Dr. Schwindt in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have high cholesterol, and 68% have high blood pressure. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schwindt's median patient age at 47, with 65% women.

In 2024, Dr. Schwindt wrote 1,388 Medicare Part D claims for 218 patients. 68% of them were for generic drugs. CMS names the drug for 1,212 of them, across 30 drugs with 11 or more claims each, at $1,135,975 in total drug cost. In 2023, CMS named 1,181 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Schwindt for performance year 2024, reported as part of a group. Dr. Schwindt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schwindt as offering telehealth.

Dmand AI links 27 papers to Dr. Schwindt, published from 2005 to 2015. 2011 was the busiest year, with 3. The most frequent topics are Exercise, Asthma and Bronchoconstriction. Dr. Schwindt has published most often in Am J Physiol Regul Integr Comp Physiol. Dr. Schwindt's most frequent co-authors are Alladdin Moh. Elhadi Abosaida, MD, Jen Jen Chen, MD and Terry Chin, MD.

CMS Open Payments shows 73 general payments to Dr. Schwindt from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Pfizer Inc. paid the most, $382.

Dr. Schwindt graduated from Saint Louis University School Of Medicine in 1993.

Dr. Schwindt is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.